HMGB1 and Renal insufficiency: This prospective, observational study demonstrates that patients with high serum HMGB1 concentrations 1 h after weaning from CPB were associated with a significantly increased risk of developing composite of morbidity endpoints after cardiac surgery, renal failure and death in particular.